首页> 外文期刊>Medical science monitor : >Treatment of patients with hepatitis C virus infection and cirrhosis
【24h】

Treatment of patients with hepatitis C virus infection and cirrhosis

机译:丙型肝炎病毒感染和肝硬化患者的治疗

获取原文
获取外文期刊封面目录资料

摘要

Patients with hepatic cirrhosis due to HCV infection should be treated with antiviral agents. The main goal of therapy in such patients is to eliminate the virus that is causing liver damage and allow the liver to recover, both in terms of fibrosis/progression and functionality. Treatment with interferons may reduce or halt progression of the liver disease and reduce the risk of HCC developmenteven in the continued presence of the virus. Other important aim of the treatment is to obtain sustained viral response (SVR). In Poland, antiviral therapy of cirrhotic patients is undertaken too rarely. The paper presents the options of therapeutic management.
机译:HCV感染引起的肝硬化患者应使用抗病毒药物治疗。在此类患者中,治疗的主要目标是消除引起肝损伤的病毒,并从纤维化/进展和功能方面使肝脏恢复。即使在持续存在病毒的情况下,用干扰素治疗也可以减少或阻止肝脏疾病的进展,并降低HCC发生的风险。该治疗的另一个重要目的是获得持续的病毒应答(SVR)。在波兰,很少对肝硬化患者进行抗病毒治疗。本文介绍了治疗管理的选项。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号